Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-30
DOI
10.1111/jcmm.13809
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacologic characterization of SHR8443, a novel dual inhibitor of phosphatidylinositol 3-kinase and mammalian target of rapamycin
- (2017) Chengying Xie et al. Oncotarget
- Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro
- (2015) M. Iraqi et al. HAEMATOLOGICA
- Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro
- (2015) M. Iraqi et al. HAEMATOLOGICA
- Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia
- (2014) William Beau Mitchell et al. AMERICAN JOURNAL OF HEMATOLOGY
- The pharmacology and clinical application of thrombopoietin receptor agonists
- (2014) Caizheng Li et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Thrombopoietin-receptor agonists
- (2012) Paul A. Basciano et al. CURRENT OPINION IN HEMATOLOGY
- A novel and simple hollow-fiber assay for in vivo evaluation of nonpeptidyl thrombopoietin receptor agonists
- (2012) Cheng-Ying Xie et al. EXPERIMENTAL HEMATOLOGY
- ROMIPLOSTIM AND ELTROMBOPAG FOR IMMUNE THROMBOCYTOPENIA: METHODS FOR INDIRECT COMPARISON
- (2012) Katy L. Cooper et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets
- (2011) Emma C. Josefsson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
- (2010) Gregory Cheng et al. LANCET
- Current status of thrombopoietic agents
- (2010) Elizabeth Rhodes et al. Expert Review of Hematology
- Use of the in Vivo Hollow Fiber Assay in Natural Products Anticancer Drug Discovery#
- (2009) Qiuwen Mi et al. JOURNAL OF NATURAL PRODUCTS
- Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
- (2009) James B Bussel et al. LANCET
- Thrombopoietin and Thrombopoietin Mimetics in the Treatment of Thrombocytopenia
- (2008) David J. Kuter Annual Review of Medicine
- The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis
- (2008) W. Nogami et al. HAEMATOLOGICA
- Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist
- (2008) Connie L. Erickson-Miller et al. STEM CELLS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now